# Kewaunee Scientific Corporation > Clarifo company profile — qualitative business description generated from > the company's filings. Financial statements, charts and ratios are > available on Clarifo (https://www.clarifo.com/fi/companies/Kewaunee Scientific Corporation). ## Overview Kewaunee Scientific designs, manufactures, and installs laboratory, healthcare, and technical furniture and infrastructure used to outfit research and clinical facilities. Its portfolio spans casework, fume hoods, workstations, biosafety cabinets, and related project services, with operations in the U.S. and international markets through its own subsidiaries and channel partners. ## Products & services • Steel and wood casework • Fume hoods and adaptable modular systems • Moveable workstations and stand-alone benches • Biological safety cabinets and CO2 incubators • Epoxy resin work surfaces and sinks • Facility design, engineering, project management, installation - **Laboratory furniture and casework** (45%) — Cabinets, benches, workstations, and modular furniture used to build out lab interiors. - **Laboratory safety and containment products** (20%) — Fume hoods, biological safety cabinets, and related containment equipment for controlled environments. - **Technical and healthcare infrastructure** (15%) — Specialized furniture and infrastructure products for healthcare, technical, and research facilities. - **Nu Aire laboratory equipment** (10%) — Biological safety cabinets, CO2 incubators, ultralow freezers, and other lab equipment added through acquisition. - **Design-build and project services** (10%) — Facility design, detailed engineering, construction support, and commissioning services. - Steel and wood casework - Fume hoods and adaptable modular systems - Moveable workstations and stand-alone benches - Biological safety cabinets and CO2 incubators - Epoxy resin work surfaces and sinks - Facility design, engineering, project management, installation ## Customers Kewaunee sells mainly to organizations building or upgrading laboratories and technical facilities, often through purchase orders, contracts, dealers, and distributors. Its end markets include pharmaceutical and biotechnology companies, industrial and chemical labs, educational institutions, healthcare institutions, government entities, and manufacturing facilities. Demand depends heavily on laboratory construction activity, project timing, and competitive public bidding. - **Pharmaceutical and biotechnology** (primary) — Buy lab furniture, containment products, and project services for R&D and quality-control facilities. - **Educational institutions** (primary) — Purchase laboratory casework and infrastructure for teaching and research labs. - **Healthcare institutions** (secondary) — Buy specialized furniture and infrastructure for clinical, diagnostic, and support spaces. - **Industrial and chemical customers** (secondary) — Use Kewaunee products for production-support and testing environments requiring durability and safety. - **Government and public sector** (secondary) — Procure through competitive bidding for laboratories and technical facilities. - **Channel partners and dealers** (primary) — Buy and resell products into project-based demand, making them strategically important to volume. - Pharmaceutical and biotechnology labs buying outfitted research spaces - Industrial and chemical laboratories needing durable, compliant work areas - Universities and educational institutions building teaching and research labs - Healthcare institutions and government entities procuring specialized facilities - Dealers and distributors that resell Kewaunee products into project pipelines ## Geography Kewaunee is headquartered in Statesville, North Carolina, with U.S. manufacturing in Statesville and Minnesota and international manufacturing in Bangalore, India. It also maintains sales offices in the United States, India, Saudi Arabia, and Singapore, supporting domestic, Asian, African, and other export markets. The Nu Aire acquisition expands its channel reach and adds distribution relationships in regions where it previously had less presence. - Headquartered in Statesville, North Carolina - U.S. manufacturing in Statesville, Plymouth, and Long Lake, Minnesota - India manufacturing in Bangalore serves local, Asian, and African markets - Sales offices in the U.S., India, Saudi Arabia, and Singapore - International subsidiaries support design, engineering, and project execution ## Strategy Kewaunee is focused on growing both organically and through acquisitions, with Nu Aire positioned as a key step in broadening its product set and channel strategy. Management is also investing in people, processes, and technology to support execution, improve manufacturing capability, and deepen its position in laboratory outfitting. The company is trying to become a broader supplier of essential lab furniture and technical products rather than a narrow casework vendor. - **Integrate Nu Aire and cross-sell the combined portfolio** (short-term) — Adds complementary products and distribution channels, broadening customer reach. - **Grow through channel expansion** (medium-term) — Dealer and distributor relationships are critical to winning project-based demand. - **Invest in manufacturing and operating capability** (medium-term) — Better execution and capacity support backlog conversion and competitive bidding. - Expand organically and inorganically to widen the addressable market - Integrate Nu Aire to add biosafety and cold-storage products - Use channel partners to reach more end markets and geographies - Invest in people, processes, and technology to support scale - Improve manufacturing capabilities and project execution reliability ## Risks Kewaunee is exposed to project timing, competitive bidding, and raw-material cost swings because its revenue depends on laboratory construction activity and fixed-price project pricing. It also has meaningful concentration with a few channel partners, making customer loss or channel disruption a material risk. International operations, supply-chain dependence, and cybersecurity/system reliability add operational and geopolitical risk. - **Channel partner concentration** [high] — Two dealers and a national stocking distributor accounted for a large share of sales, so loss of one would hit revenue and profit. - **Project timing and backlog conversion** [high] — Revenue depends on laboratory construction projects, which can be delayed or accelerated by customer decisions and site progress. - **Raw material inflation** [medium] — Steel, wood, and epoxy resin are key inputs, so price swings can reduce margins if not passed through. - **Cybersecurity and IT disruption** [high] — Systems support manufacturing, inventory, sales transactions, and shipping; outages can halt operations. - **International regulatory and geopolitical exposure** [medium] — Operations across multiple countries create exposure to sanctions, customs, export controls, and local compliance regimes. - Customer concentration with major channel partners can materially affect sales - Project timing and lab construction cycles can create uneven quarterly results - Steel, wood, and epoxy resin costs can pressure margins on fixed-price jobs - Competitive public bidding can compress pricing and win rates - IT and cybersecurity failures could disrupt manufacturing, shipping, and customer service ## Accounting Revenue is largely project-based and can be affected by contract timing, backlog conversion, and quarter-to-quarter shipment patterns, which makes comparability uneven. The Nu Aire acquisition introduces goodwill and intangible assets that require ongoing impairment testing, while lease and debt obligations also affect reported leverage and cash flow presentation. Investors should also watch estimates tied to acquisition accounting, fair value allocation, and any future impairment charges. - **Revenue recognition on project contracts** — Quarterly revenue and margin volatility - **Goodwill and intangible assets** — Potential non-cash impairment charges - **Lease and sale-leaseback accounting** — Reported leverage and future cash commitments - **Acquisition purchase price allocation** — Future amortization and impairment profile - Project-based revenue timing can shift results between quarters - Acquisition accounting creates goodwill and identifiable intangibles - Goodwill and intangible impairment testing can create non-cash charges - Lease and sale-leaseback obligations affect balance sheet leverage - Debt and seller note accounting affect liquidity and interest expense --- *Last updated: 2026-09-24T11:23:42.083122+00:00*